CD20 188-196 (HLA-A*02:01)
( SLFLGILSV )
SLFLGILSV is a linear peptidic epitope (epitope ID140742) studied as part of B-lymphocyte antigen CD20 from Homo sapiens (human), tested in T cell assays CD20 188-196 (HLA-A*02:01) SLFLGILSV for stimulation of T-cells. Single peptide (SLFLGILSV) for stimulation of human CD20 (188-196)-specific CD8+ T-cells.
Sequence: | SLFLGILSV | |
Gene: | MS4A1 | |
Delivery: | 3 weeks | |
C-Terminus: | OH | |
N-Terminus: | H | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | B-lymphocyte antigen CD20 | |
Species: | Human | |
Allele: | HLA-A*02:01 | |
Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
Indication : | Cancer | |
Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€60.40*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Product number:
EP07888_1